Inventor · disambiguated record
Sze-Wan Li
Also filed as: LI SZE-WAN
28 granted patents·7 pending applications·202 citations·filing 2008–2023
96Inventor score
Top patents by PatentIndex Score
35 records- 0195US8263596B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2011·Granted Sep 11, 2012·26 cites·10 claims
- 0294US9657025B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2015·Granted May 23, 2017·11 cites·2 claims
- 0394US9139563B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2013·Granted Sep 22, 2015·14 cites·9 claims
- 0494US8481533B2Kinase inhibitors and method of treating cancerSAMPSON PETER B·Filed 2012·Granted Jul 9, 2013·24 cites·20 claims
- 0592US9907800B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2015·Granted Mar 6, 2018·7 cites·6 claims
- 0692US9573954B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2013·Granted Feb 21, 2017·13 cites·22 claims
- 0791US8481525B2Kinase inhibitors and method of treating cancer with sameSAMPSON PETER BRENT·Filed 2010·Granted Jul 9, 2013·27 cites·33 claims
- 0890US10358436B2Kinase inhibitors and method of treating cancerUNIV HEALTH NETWORK·Filed 2018·Granted Jul 23, 2019·4 cites·6 claims
- 0990US8999968B2Kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2013·Granted Apr 7, 2015·13 cites·13 claims
- 1089US8921545B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesCUMMING GRAHAM·Filed 2011·Granted Dec 30, 2014·15 cites·14 claims
- 1189US8765748B2Indazolyl, benzimidazolyl, benzotriazolyl substituted indolinone derivatives as kinase inhibitors useful in the treatment of cancerPAULS HEINZ W·Filed 2008·Granted Jul 1, 2014·16 cites·17 claims
- 1288US10501474B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2016·Granted Dec 10, 2019·3 cites·2 claims
- 1388US2024287077A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2023·Application pending·0 cites
- 1487US10106545B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Oct 23, 2018·4 cites·21 claims
- 1587US9796703B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Oct 24, 2017·4 cites·9 claims
- 1686US10584130B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2017·Granted Mar 10, 2020·2 cites·22 claims
- 1786USRE47731EKinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2018·Granted Nov 19, 2019·4 cites·13 claims
- 1886US9579327B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2014·Granted Feb 28, 2017·5 cites·16 claims
- 1984US11104681B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2020·Granted Aug 31, 2021·1 cites·19 claims
- 2084US10570143B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Granted Feb 25, 2020·2 cites·21 claims
- 2184US10167289B2Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2017·Granted Jan 1, 2019·2 cites·16 claims
- 2283US10077255B2Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-onesUNIV HEALTH NETWORK·Filed 2017·Granted Sep 18, 2018·2 cites·25 claims
- 2381US8980934B2Kinase inhibitors and method of treating cancer with samePAULS HEINZ W·Filed 2013·Granted Mar 17, 2015·3 cites·21 claims
- 2479US11878980B2Solid forms of TTK inhibitorUNIV HEALTH NETWORK·Filed 2021·Granted Jan 23, 2024·0 cites·8 claims
- 2579US2022204511A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 2673US2021009595A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 2769US11059832B2HPK1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2019·Granted Jul 13, 2021·0 cites·10 claims
- 2869US2022002313A1Hpk1 inhibitors and methods of using sameUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 2969US2019322669A1Pyrazolopyrimidine compoundsUNIV HEALTH NETWORK·Filed 2018·Application pending·0 cites
- 3068US10875863B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2019·Granted Dec 29, 2020·0 cites·15 claims
- 3164US2021261554A1Ripk2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2020·Application pending·0 cites
- 3256US10239881B2RIPK2 inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2015·Granted Mar 26, 2019·0 cites·16 claims
- 3353US12325700B2Crystal form S4 of the PLK4 inhibitor (1R,2S)-(e)-2-(3-(4-((cis-2,6-dimethylmorpholino)methyl)styryl)-1 h-imidazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one fumarateUNIV HEALTH NETWORK·Filed 2020·Granted Jun 10, 2025·0 cites·25 claims
- 3453US2023174549A1Salt and crystal forms of 4-amino-5-(6-(4-methylpiperazin-1-yl)-1h-benzo[d]imidazol-2-yl)thieno[2,3-b]pyridin-6(7h)-oneUNIV HEALTH NETWORK·Filed 2021·Application pending·0 cites
- 3543US9580390B2Indazole compounds as kinase inhibitors and method of treating cancer with sameUNIV HEALTH NETWORK·Filed 2012·Granted Feb 28, 2017·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →